Traders Purchase Large Volume of SPDR S&P Biotech ETF Call Options (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the recipient of some unusual options trading on Thursday. Stock investors purchased 57,758 call options on the stock. This represents an increase of 47% compared to the typical daily volume of 39,379 call options.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Vertrix Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 5.0% during the third quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock worth $237,000 after purchasing an additional 71 shares during the period. Compound Planning Inc. grew its position in shares of SPDR S&P Biotech ETF by 0.7% during the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after buying an additional 75 shares during the period. PeakShares LLC increased its stake in shares of SPDR S&P Biotech ETF by 5.2% in the 1st quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after acquiring an additional 84 shares during the last quarter. Centaurus Financial Inc. raised its position in shares of SPDR S&P Biotech ETF by 11.4% in the 1st quarter. Centaurus Financial Inc. now owns 1,254 shares of the exchange traded fund’s stock valued at $160,000 after acquiring an additional 128 shares during the period. Finally, First Heartland Consultants Inc. raised its position in shares of SPDR S&P Biotech ETF by 1.3% in the 2nd quarter. First Heartland Consultants Inc. now owns 9,709 shares of the exchange traded fund’s stock valued at $1,536,000 after acquiring an additional 128 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded up $2.92 during trading on Thursday, hitting $149.69. 6,829,601 shares of the stock were exchanged, compared to its average volume of 9,148,860. The company’s fifty day simple moving average is $158.45 and its 200-day simple moving average is $146.68. The company has a market capitalization of $10.03 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.